Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1656 1683 1759
This examiner grants 73% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17781873 | CHO CELL-DERIVED PROTEIN SECRETORY FACTORS AND EXPRESSION VECTORS COMPRISING THE SAME | Non-Final OA | LG CHEM, LTD |
| 18691748 | MODIFIED PROTEIN DISULFIDE ISOMERASE AND USES THEREOF | Non-Final OA | The University of North Carolina at Chapel Hill |
| 18044504 | Therapeutic Antibody Formulations | Non-Final OA | Eli Lilly and Company |
| 17822992 | Methods For The Identification Of UBQLN2-Mediated Amyotrophic Lateral Sclerosis (ALS) | Non-Final OA | The Regents of the University of Colorado, a body corporate |
| 18540158 | Modified Pyrococcus Polymerases and Uses Thereof | Non-Final OA | Singular Genomics Systems, Inc. |
| 17786557 | CLEANING COMPOSITIONS COMPRISING DISPERSINS IX | Non-Final OA | Henkel AG & Co. KGaA |
| 18634640 | COMPLEX FOR GENOME EDITING HAVING STABILITY AND FEW SIDE-EFFECTS, AND NUCLEIC ACID CODING SAME | Non-Final OA | National University Corporation Kobe University |
| 18246607 | RECOMBINANT YEAST FOR THE PRODUCTION OF OLIGOPEPTIDE | Non-Final OA | LESAFFRE ET COMPAGNIE |
| 18545528 | REMOVAL OF SERINE PROTEASES BY TREATMENT WITH FINELY DIVIDED SILICON DIOXIDE | Final Rejection | Takeda Pharmaceutical Company Limited |
| 17999356 | DRUG CONTAINING ACTIVE SULFUR COMPOUND AS ITS MAIN COMPONENT | Non-Final OA | Bio-Xcelerator, Inc. |
| 18460178 | USES OF ADENOSINE BASE EDITORS | Final Rejection | Beam Therapeutics Inc. |
| 17697043 | BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDE REBAUDIOSIDE D4 FROM REBAUDIOSIDE E | Non-Final OA | Conagen Inc. |
| 17912066 | FRAGMENTS OF HLYA AND USES THEREOF | Non-Final OA | NUMAFERM GmbH |
| 18051109 | HYPERACTIVE PIGGYBAC TRANSPOSASES | Non-Final OA | Poseida Therapeutics, Inc. |
| 18270879 | METHOD FOR PRODUCING GENETICALLY MODIFIED CELLS | Non-Final OA | Horizon Discovery Limited |
| 18052029 | CATION CHELATOR HOT START | Non-Final OA | Qiagen GmbH |
| 18036611 | TRANSFORMANT AND METHOD FOR PRODUCING CAROTENOID COMPOSITION USING SAME | Non-Final OA | EZAKI GLICO CO., LTD. |
| 17786997 | A RECOMBINANT FILAMENTOUS FUNGUS FOR PRODUCING ETHANOL AND ITS CONSTRUCTION AND APPLICATION | Non-Final OA | TIANJIN INSTITUTE OF INDUSTRIAL BIOTECHNOLOGY, CHINESE ACADEMY OF SCIENCES |
| 17791667 | MUSCLE-TARGETING COMPLEXES AND USES THEREOF | Final Rejection | Dyne Therapeutics, Inc. |
| 18151752 | Method, Compositions and Applications of Mechanosensitive Channels | Non-Final OA | Nanoscope Technologies LLC |
| 17909971 | SELECTABLE MARKER PROTEINS, EXPRESSION VECTORS, ENGINEERED CELLS AND EXTRACELLULAR VESICLES FOR THE PRODUCTION OF VIRUS-LIKE PARTICLES FOR THERAPEUTIC AND PROPHYLACTIC APPLICATIONS | Non-Final OA | Capricor, Inc. |
| 17802560 | Recombinant microalgae able to produce peptides, polypeptides or proteins of collagen, elastin and their derivatives in the chloroplast of microalgae and associated method thereof | Non-Final OA | ALGANELLE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy